实用医学杂志 ›› 2021, Vol. 37 ›› Issue (18): 2360-2365.doi: 10.3969/j.issn.1006⁃5725.2021.18.011

• 临床研究 • 上一篇    下一篇

心脏瓣膜钙化和颈动脉粥样硬化对维持性腹膜透析患者预后的影响

张悦, 华佳, 刘晓斌, 张希燃, 薛婧, 王凉   

  1. 南京医科大学附属无锡人民医院(江苏无锡 214023)

  • 出版日期:2021-09-25 发布日期:2021-09-25
  • 通讯作者: 王凉 E⁃mail:wangliang_wuxi@126.com
  • 基金资助:
    江苏省“333 工程”基金资助项目(编号:BRA2020142);江苏省卫生健康委科研项目(编号:LGY201801);南京医科大学科技发展基金⁃面上项目(编号:2017NJMU204)

Association of cardiac valve calcification and carotid atherosclerosis on prognosis in maintenance peritoneal dialysis patients

ZHANG YueHUA JiaLIU XiaobinZHANG XiranXUE JingWANG Liang. Wuxi   

  1. People′s Hospital Affiliated to Nanjing Medical University,Wuxi 214023,China

  • Online:2021-09-25 Published:2021-09-25
  • Contact: WANG Liang E⁃mail:wangliang_wuxi@126.com

摘要:

目的 分析心脏瓣膜钙化(cardiac valve calcification,CVC)和颈动脉粥样硬化(carotid athero⁃ sclerosis,CAS)对维持性腹膜透析患者预后的影响,并探讨联合 2 个指标预测腹膜透析患者全因死亡和心 血管死亡的价值。方法 2015  7⁃12 月在南京医科大学附属无锡人民医院腹膜透析中心行持续性非卧床腹膜透析(CAPD)或日间非卧床腹膜透析(DAPD)治疗≥3 个月的腹膜透析患者,收集患者一般临床资 料、实验室检查结果,并行心脏超声和颈动脉超声检查。将CVC、CAS均作为危险标记,将患者分为3组:0 1、2个危险标记组。随访所有患者至死亡、退出腹膜透析或至研究终止(2020  6  30 日)。通过 Kaplan⁃ Meier 法分析 3 组患者全因死亡和心血管死亡。Cox比例风险模型分析0、1和2个危险标记对患者全因死亡 和心血管死亡的预测作用。结果 入选 166 例腹膜透析患者,46(27.7%)例存在 CVC,88(53.0%)例存在 CAS。70例患者无危险标记,58例存在1个危险标记(CVC  CAS),38 例存在 2 个危险标记(CVC  CAS)。 至研究终止,34 例患者死亡,其中 21 例死于心血管疾病。Kaplan⁃Meier 生存分析提示3组间全因死亡及心 血管死亡差异具有统计学意义(< 0.001)。Cox 回归分析显示与无危险标记的患者相比,2  1 个危险标 记的患者的全因死亡 HR 分别为 8.011(95%CI:2.493 ~ 25.741,= 0.001)和2.711(95%CI:0.820 ~ 8.961,= 0.102),心血管死亡的 HR 分别为 6.734(95%CI:1.643 ~ 27.610,= 0.008)和 1.694(95%CI:0.385 ~ 7.460 = 0.486)。与任何 1个危险标记相比,联合使用 2 个危险标记预测全因死亡和心血管死亡的受试者曲线下面积(AUC)均增大。结论 CVC  CAS 是影响腹膜透析患者危险因素,联合 2 个指标可更好地预测腹透患者的预后

关键词:

心脏瓣膜钙化, 颈动脉粥样硬化, 腹膜透析, 全因死亡, 心血管死亡

Abstract:

Objective To analyze the association of cardiac valve calcification(CVC)and carotid athero⁃ sclerosis(CAS)on the prognosis in maintenance peritoneal dialysis patients,and to investigate the value of combin⁃ ing CVC and CAS on all⁃cause and cardiovascular mortality in PD patients. Methods Patients underwent regular PD duration of ≥ 3 months in PD center of Wuxi people′s hospital affiliated to Nanjing Medical University from July 2015 to December 2015 were enrolled in this study. Their clinical and laboratory information was gathered,cardiac echocardiography and carotid artery color Doppler ultrasound examination were performed in the patients. CVC and CAS are considered as risk markers,The patients were assigned to three groups based on their risk markers(0 1,and 2). All patients were followed up until death,PD discontinuation,or study termination(June 30,2020). The Kaplan⁃Meier method was used to analyze all⁃cause and cardiovascular mortality. The Cox proportional hazard model was used to analyze the prediction of all⁃cause mortality and cardiovascular mortality by risk markers 0,1 and 2. Results A total of 166 patients with PD were enrolled,46(27.7%)patients were with CVC and 88(53.0% patients were with CAS,70(42.2%)patients had no risk markers,58(34.9%)patients had 1 risk marker(CVC or CAS),and 38(22.9%)patients had 2 risk markers(CVC and CAS). By the end of the study,34 patients had died and 21 patients were due to cardiovascular events. According to the Kaplan⁃Meier,differences in all⁃cause and cardiovascular mortality between the three groups(P < 0.001). The Cox regression analysis revealed that the HR for all⁃cause mortality in PD patients with 2 and 1 risk markers were 8.011(95%CI 2.493 ~ 25.741,P = 0.001)and 2.711(95%CI:0.820 ~ 8.961,P = 0.102),and the HR for cardiovascular mortality was 6.734(95%CI:1.643 ~ 27.610,P = 0.008)and 1.694(95%CI:0.385 ~ 7.460,P = 0.486),compared with those without risk markers. When combined with both risk markers,the area under the curve(AUC)of all⁃cause and cardiovascular mortality increased when compared to any single risk marker. Conclusion CVC and CAS are risk markers for PD patients,and the combination of these two markers can better predict PD patient prognosis.

Key words:

cardiac valve calcification, carotid atherosclerosis, peritoneal dialysis, all?cause mor? tality, cardiovascular mortality